Atlas Trials

Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes

Clinical trial NCT02950987 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02950987
Sponsor
Dana-Farber Cancer Institute
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Li-Fraumeni Syndrome
Start date
2012-03-01
Primary completion
2027-12-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.